2-Hydroxyphenylacetic acid

Elevated levels of 2-hydroxyphenylacetic acid are commonly associated with increased bacterial metabolism of tyrosine in the gut, often reflecting intestinal dysbiosis or bacterial overgrowth. This marker may indicate that amino acid metabolism is being shifted toward microbial pathways rather than normal human biochemical processing.

In addition to microbiome imbalance, elevated levels may also be influenced by dietary intake of phenylalanine or tyrosine, or by impaired downstream metabolism. Suboptimal oxygen delivery—such as in iron deficiency, anemia, or pulmonary conditions—can further alter these metabolic pathways. Low levels of tetrahydrobiopterin (BH4), an essential cofactor involved in the metabolism of phenylalanine, tyrosine, tryptophan, and nitric oxide synthesis, may also contribute to elevated levels.

Potential Contributing Factors:

• Gut dysbiosis or bacterial overgrowth (e.g., SIBO)
• High dietary intake of phenylalanine or tyrosine
• Impaired amino acid metabolism
• Reduced oxygenation (iron deficiency, anemia, pulmonary or cardiovascular conditions)
• Low tetrahydrobiopterin (BH4) availability

Additional Investigations to Consider:

• Urinary amino acids profile
• Iron studies (including ferritin)
• Markers of oxygenation and overall metabolic status

Clinical Considerations:

• Evaluate and moderate excessive intake of phenylalanine and tyrosine if relevant
• Address underlying gut imbalance (e.g., targeted antimicrobials, probiotics, or dietary interventions)
• Correct contributing factors such as iron deficiency, anemia, or impaired oxygen delivery
• Support BH4 pathways, where appropriate, through nutrients such as vitamin C and active folate (5-MTHF), which may help support nitric oxide production and amino acid metabolism

Low levels of 2-hydroxyphenylacetic acid are generally not considered clinically significant and often reflect balanced or efficient metabolism of tyrosine. This may indicate that amino acid processing is occurring through normal human biochemical pathways, with minimal excess contribution from gut bacterial metabolism.

In some cases, lower levels may be associated with reduced microbial activity in the gut or lower dietary intake of phenylalanine and tyrosine. This pattern is often seen in individuals with a well-balanced microbiome or those consuming lower-protein diets.

Potential Contributing Factors:

• Balanced gut microbiome with low excess bacterial fermentation
• Efficient tyrosine and phenylalanine metabolism
• Lower dietary intake of protein or amino acids
• Reduced microbial activity in the gut

Additional Investigations to Consider:

• Typically not required if no symptoms are present
• Consider broader metabolic or microbiome context if clinically indicated

Clinical Considerations:

• No intervention is usually necessary in isolation
• Interpret alongside other organic acids and clinical symptoms
• Maintain a balanced diet to support overall metabolic and microbiome health

2-Hydroxyphenylacetic acid is a metabolite produced during the breakdown of the amino acid tyrosine, often influenced by gut bacteria. On a Vibrant Organic Acids test, its levels can provide insight into microbial activity and amino acid metabolism. Abnormal levels may reflect imbalances in the gut microbiome or altered metabolic processes.